| ATP | Adenosine triphosphate |
| CD27/28/57 | Cluster of differentiation 27/28/57 |
| CoQ10 | Coenzyme Q10 |
| CSF | Cerebrospinal fluid |
| CTLA-4 | Cytotoxic T-lymphocyte-associated antigen 4 |
| DAMPs | Damage-associated molecular patterns |
| DNAM-1 | DNAX accessory molecule 1 |
| EOMES | Eomesodermin |
| FAO | Fatty acid oxidation |
| Gal-9 | Galectin-9 |
| HCs | Healthy controls |
| HIV | Human immunodeficiency virus |
| IFN-γ | Interferon gamma |
| IL-2/6/10 | Interleukin 2/6/10 |
| KIR | Killer cell immunoglobulin-like receptors |
| KLRG-1 | Killer cell lectin-like receptor G1 |
| LAG-3 | Lymphocyte-activation gene 3 |
| MAVS | Mitochondrial antiviral signalling proteins |
| ME/CFS | Myalgic Encephalomyelitis/Chronic Fatigue Syndrome |
| mtDNA | Mitochondrial DNA |
| NF-κB | Nuclear factor kappa B |
| NK cell | Natural killer cell |
| NKG2A/D | Natural killer group 2A/D |
| OXPHOS | Oxidative phosphorylation |
| PBMCs | Peripheral blood mononuclear cells |
| PD-1 | Programmed cell death protein 1 |
| PEM | Post-exertional malaise |
| RNS | Reactive nitrogen species |
| ROS | Reactive oxygen species |
| SASP | Senescence-associated secretory phenotype |
| T-bet | T-box expressed in T-cells |
| TCF-1 | T cell factor 1 |
| TIGIT | T-cell immunoreceptor with Ig and ITIM domains |
| TIM-3 | T-cell immunoglobulin and mucin domain 3 |
| TNF-α | Tumour necrosis factor alpha |
| TORC1 | Target of Rapamycin Complex I |